Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

(Reuters) - Eli Lilly's blockbuster diabetes drug Mounjaro and weight-loss therapy Zepbound, as well as Novo Nordisk's rival ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

A new analysis of 11 global studies shows that people tend to regain lost weight after stopping anti-obesity medications like ...

Obesity is not a personal moral failing. It is a complex, multi-factorial condition driven by genetics, environment, and a ...

Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

People with diabetes who used semaglutide or other GLP-1 agonists were also less likely to see a provider for depression.

A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...

RELATED: Doctors Warn That Drugs Like Ozempic Are Making You “Skinny Fat.” Any time a person suddenly loses weight, they are ...